Japan: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2022

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in Japan

The Japanese market for medicaments of alkaloids or derivatives thereof rose significantly to $X in 2021, increasing by X% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption showed a prominent increase. Consumption of peaked in 2021 and is expected to retain growth in years to come.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports from Japan

In 2021, after two years of decline, there was significant growth in shipments abroad of medicaments of alkaloids or derivatives thereof, when their volume increased by X% to X tons. In general, exports, however, showed a pronounced contraction. The exports peaked at X tons in 2018; however, from 2019 to 2021, the exports stood at a somewhat lower figure.

In value terms, exports of medicaments of alkaloids or derivatives thereof surged to $X in 2021. Overall, exports saw a slight expansion. Over the period under review, the exports of hit record highs at $X in 2018; however, from 2019 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Macao SAR (X tons) was the main destination for exports of medicaments of alkaloids or derivatives thereof from Japan, with a X% share of total exports. Moreover, exports of medicaments of alkaloids or derivatives thereof to Macao SAR exceeded the volume sent to the second major destination, the United States (X tons), threefold. Saudi Arabia (X tons) ranked third in terms of total exports with an X% share.

From 2012 to 2021, the average annual growth rate of volume to Macao SAR totaled +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (+X% per year) and Saudi Arabia (-X% per year).

In value terms, the United States ($X) remains the key foreign market for medicaments of alkaloids or derivatives thereof exports from Japan, comprising X% of total exports. The second position in the ranking was held by Saudi Arabia ($X), with a X% share of total exports. It was followed by Canada, with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of value to the United States totaled +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Saudi Arabia (-X% per year) and Canada (+X% per year).

Export Prices by Country

The average export price for medicaments of alkaloids or derivatives thereof stood at $X per ton in 2021, shrinking by -X% against the previous year. Over the period under review, the export price, however, showed a temperate increase. The pace of growth appeared the most rapid in 2018 an increase of X%. As a result, the export price attained the peak level of $X per ton. From 2019 to 2021, the the average export prices remained at a somewhat lower figure.

There were significant differences in the average prices for the major export markets. In 2021, the country with the highest price was the United States ($X per ton), while the average price for exports to Macao SAR ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Malaysia (+X%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports into Japan

For the tenth consecutive year, Japan recorded growth in purchases abroad of medicaments of alkaloids or derivatives thereof, which increased by X% to X tons in 2021. Overall, imports saw prominent growth. As a result, imports attained the peak and are likely to continue growth in the immediate term.

In value terms, imports of medicaments of alkaloids or derivatives thereof rose sharply to $X in 2021. In general, imports posted a remarkable increase. The growth pace was the most rapid in 2016 when imports increased by X% against the previous year. Imports peaked in 2021 and are likely to continue growth in the near future.

Imports by Country

In 2021, China (X tons) constituted the largest supplier of medicaments of alkaloids or derivatives thereof to Japan, with a X% share of total imports. Moreover, imports of medicaments of alkaloids or derivatives thereof from China exceeded the figures recorded by the second-largest supplier, Belgium (X tons), sevenfold.

From 2012 to 2021, the average annual rate of growth in terms of volume from China totaled +X%.

In value terms, China ($X) constituted the largest supplier of medicaments of alkaloids or derivatives thereof to Japan, comprising X% of total imports. The second position in the ranking was taken by Belgium ($X), with a X% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of value from China stood at +X%.

Import Prices by Country

The average import price for medicaments of alkaloids or derivatives thereof stood at $X per ton in 2021, dropping by -X% against the previous year. Over the period under review, the import price recorded a mild slump. The growth pace was the most rapid in 2015 when the average import price increased by X% against the previous year. The import price peaked at $X per ton in 2016; however, from 2017 to 2021, import prices failed to regain momentum.

Average prices varied noticeably amongst the major supplying countries. In 2021, the country with the highest price was Belgium ($X per ton), while the price for China stood at $X per ton.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+X%).

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :